SUVRETTA CAPITAL MANAGEMENT, LLC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1569064
New York, NY
Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$37,913,685
+$16,930,347 QoQ
Shares Held
1,043,879
-7.2% QoQ
Ownership
0.990%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,459,096,047 across 36 Biotechnology names. CRNX ranks #21 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
12,327,000 | $290,424,120 | |
| 2 | MANE |
Veradermics, Inc
|
4,168,970 | $263,270,455 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
1,153,496 | $143,783,276 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
3,518,471 | $141,548,088 | |
| 5 | LEGN |
Legend Biotech Corp
|
7,581,029 | $137,140,814 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
11,548,351 | $122,989,938 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
3,818,600 | $116,085,440 | |
| 8 | IMTX |
Immatics N.V.
|
11,190,129 | $110,110,869 |
All Filings in CRNX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,913,685 | 1,043,879 | Shares | Sole | 2026-05-15 | |
| 2022-06-30 | $20,983,338 | 1,125,112 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||